Virometix offers an innovative solution to the problem of designing and manufacturing the next generation of vaccine-based drugs. They have developed a technology to produce synthetic, virus-like particles that can be used instead of biologically produced vaccines. A major advantage of the new process is the ability to do without additives and risk of contamination in the vaccine.